1578
KHACHIKYAN et al.
Table 2. NMR spectral data (DMSO-d6–CCl4, 1 : 3) for compounds 2–6
Comp no.
δ, ppm (J, Hz)
2a
δН: 6.60 d (1H, H4, pyrazole, J = 2.2), 7.18–7.22 m (2H, C6H4), 6.62–7.75 m (1H, H5, pyrazole; 2H, C6H4), 9.00
br. S (2H, H1,2, pyrazole)
2b
2c
4a
δН: 6.60 d (1H, H4, pyrazole, J = 2.2), 7.33–7.38 m (2H, C6H4), 7.63 d (1H, H5, pyrazole, J = 2.2), 7.74–.79 m
(2H, C6H4), 8.68 br.s (2H, H1,2, pyrazole)
δН: 6.63 d (1H, H4, pyrazole, J = 2.2), 7.50–7.55 m (2H, C6H4), 7.64 d (1H, H5, pyrazole, J = 2.2), 7.78–7.80 m
(2H, C6H4), 9.20 br.s (2H, H1,2, pyrazole)
δН: 2.45 s (3H, CH3), 2.46 s (3H, CH3), 7.28–7.35 m (4H, C6H4), 7.42 d (1H, SCH=CH, J = 10.0), 7.72 d (1H,
CH=CHN, J = 5.3), 7.88–7.95 m (2H, C6H4), 8.07–8.13 m (2H, C6H4), 8.70 d (1H, CH=CHN, J = 5.3), 8.86 d
(1H, SCH=CH, J = 10.0)
δC: 20.9 (CH3), 21.0 (CH3), 113.2 (CH=CHN), 116.8 (SCH=CH), 126.8, 127.8, 128.8, 129.1, 132.5, 134.6,
141.0, 142.4, 142.5 (SCH=CH), 157.7 (CH=CHN), 163.4 168.4, 187.2 (CO).
4b
4c
5a
δН: 7.59–7.65 m (5H, C6H4 + pyrimidine), 7.98 d (1H, CH=CHN, J = 5.3), 7.08–8.12 m (2H, C6H4), 8.26–8.31 m
(2H, C6H4), 8.85 d (1H, CH=CHN, J = 5.3), 8.90 d (1H, SCH, J = 9.9)
δН: 7.53 d (1H, SCH=CH, J = 10.0), 7.68–7.74 m (4H, C6H4), 7.91 d (1H, CH=CHN, J = 5.3), 7.97–8.02 m (2H,
C6H4), 8.17–8.22 m (2H, C6H4), 8.80 d (1H, CH=CHN, J = 5.3), 8.90 d (1H, SCH=CH, J = 10.0)
δН: 2.36 s (3H, CH3), 2.50 s (3H, CH3), 7.15–7.20 m (2H, C6H4), 7.37–7.50 m (7H, C6H5 + C6H4), 7.76–7.80 m
(2H, C6H4), 8.02–8.06 m (2H, C6H4), 8.39 d (1H, C5H3N+, J = 8.2), 8.95 d.d (1H, C5H3N+, J = 8.2, 1.8), 9.19 d
(1H, C5H3N+, J = 1.8)
δC: 20.8 (CH3), 21.2 (CH3), 126.6, 128.6, 128.7, 128.8, 129.2, 129.7, 130.0, 130.3, 130.5, 132.3, 135.3, 140.4,
141.9, 144.5, 145.3, 146.9 (NCH), 156.9, 189.2 (CO)
5b
5c
δН: 7.37–7.42 m (2H, C6H4), 7.48–7.55 m (3H, C6H5), 7.65–7.70 m (4H, C6H5 + C6H4), 7.88–7.99 m (4H,
ClC6H4CO), 8.52 d (1H, C5H3N+, J = 8.2), 9.09 d.d (1H, C5H3N+, J = 8.2, 1.7), 9.60 d (1H, C5H3N+, J = 1.7)
δН: 7.35–7.40 m (2H, C6H4), 7.48–7.55 m (3H, C6H5), 7.61–7.65 m (2H, C6H5), 7.65–7.70 m (2H, C6H4), 7.87–
7.95 m (4H, BrC6H4CO), 8.51 d (1H, C5H3N+, J = 8.2), 9.07 d.d (1H, C5H3N+, J = 8.2, 1.8), 9.56 d (1H, C5H3N+,
J = 1.8)
6a
δН: 2.2 s (3H, CH3), 6.02 d (0.75H, =CHCO, J = 7.8), 6.37 d (0.25H, =CHCO, J = 12.5), 6.92 br.t (0.25H, Ph,
(Z : E =
3 : 1)
J
= 7.3), 7.02 br.t (0.75H, Ph, J = 7.3), 7.05–7.11 m (0.5H, Ar), 7.18–7.38 m (5.5H, Ar), 7.68 d.d
(0.75H, =CHN, J = 12.1, 8.0), 7.76–7.79 m (0.5H, Ar), 7.80–7.83 m (1.5H, Ar), 8.03 d.d (0.25H =CHN, J =
12.9, 12.5), 9.80 br.d (0.25H, NH, J = 12.9), 12.10 br.d (0.75H, NH, J = 12.1)
6b
δН: 6.10 d (0.7H, =CHCO, J = 7.8), 6.40 d (0.3H, =CHCO, J = 12.4), 7.04 br.t (0.3H, 4-H, Ph, J = 7.5), 7.12 br.t
(Z : E = (0.7H, 4-H, Ph, J = 7.5), 7.18–7.20 m (0.6H, Ar), 7.27–7.40 m (3.4H, Ar), 7.56–7.60 m (2H, Ar), 7.81–7.85 d.d
7 : 3)
(0.7H, =CHN, J = 12.5, 7.8), 7.84–7.87 m (0.6H, Ar), 7.87–8.00 m (1.4H, Ar), 8.13 d.d (0.3H, =CHN, J = 13.1,
12.4), 10.20 br.d (0.3H, NH, J = 13.1), 12.10 br.d (0.7H, NH, J = 12.4)
6c
δН: 6.02 d (0.7H, =CHCO, J = 7.8), 6.34 d (0.3H, =CHCO, J = 12.4), 6.95 br.t (0.3H, 4-H, Ph, J = 7.3), 7.04 br.t
(Z : E = (0.7H, 4-H, Ph, J = 7.3), 7.09–7.14 m (0.6H, Ar), 7.19–7.37 m (3.4H, Ar), 7.55–7.60 m (2H, Ar), 7.76 d.d (0.7H,
7 : 3)
=CHN, J = 12.4, 7.8), 7.77–7.81 m (0.6H, Ar), 7.81–7.86 m (1.4H, Ar), 8.11 d.d (0.3H, =CHN, J = 13.1, 12.4),
9.92 br.d (0.3H, NH, J = 13.1), 12.14 br.d (0.7H, NH, J = 12.4)
Structure of compounds obtained was established
molecules whose position with respect to each other is
characterized by an inversion pseudocenter (0.97 0.62
0.24), which is an apparent cause of twinning. All
cyclic fragments of compound 5a are planar. The
maximum deviation of the atoms from the average
plane of the benzene ring does not exceed 0.0092(2)
(Ph), 0.0051(3) (p-Tol), 0.0252(3) (Py) and 0.0210(2) Å
[4-CH3C(O)Ph].
1
by H and 13C NMR spectroscopy methods (Tables 1
and 2). Two-dimensional NOESY and HMQC
techniques were used for assigning signals.
Structure of compound 5a was confirmed by X-ray
diffraction analysis (see figure). As show XRD data
the unit cell contains two symmetrically nonequivalent
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 86 No. 7 2016